Acceleration of Wound Healing in Diabetic Mice by Basic Fibroblast Growth Factor

Overview

Journal Biol Pharm Bull

Specialty Biochemistry

Date 1996 Apr 1

PMID 8860952

Citations 25

Authors

M Okumura

T Okuda

T Nakamura

M Yajima

Affiliations

Soon will be listed here.

Abstract

We studied the effect of recombinant human basic fibroblast growth factor (bFGF) on wound healing in genetically diabetic mice. Wound closure after full-thickness excision of skin was markedly delayed in diabetic mice compared to normoglycemic mice. A single application of bFGF caused a marked acceleration of wound healing in a dose-dependent manner. There were no hypertrophic scars or unlimited granulation tissue formation in regenerated tissues treated with any doses of bFGF under histological examination. The repeated application of bFGF for 7 d showed a bell-shaped dose-response in the rate of wound closure, and the optimal dose was as small as 0.2-2 mu g per wound. Reduced angiogenesis and granulation tissue formation were observed in diabetic mice compared to normal mice, and bFGF treatment restored both responses to significant levels. The beneficial effect of bFGF on wound healing would be largely explained by enhanced angiogenesis and granulation tissue formation.

Citing Articles

Latest update on the use of recombinant growth factors for periodontal regeneration: existing evidence and clinical applications.

Khehra A, Shiba T, Chen C, Kim D Ther Adv Chronic Dis. 2024; 15:20406223241302707.

PMID: 39619169 PMC: 11605760. DOI: 10.1177/20406223241302707.

Concomitant heparin use promotes skin graft donor site healing by basic fibroblast growth factor: A pilot prospective randomized controlled study.

Kohyama K, Kato H, Okada H, Ishihara T, Yasue Y, Kamidani R Contemp Clin Trials Commun. 2024; 42:101375.

PMID: 39398328 PMC: 11470421. DOI: 10.1016/j.conctc.2024.101375.

Periodontal regenerative therapy using recombinant human fibroblast growth factor (rhFGF)-2 in combination with carbonate apatite granules or rhFGF-2 alone: 12-month randomized controlled trial.

Imamura K, Yoshida W, Seshima F, Aoki H, Yamashita K, Kitamura Y Clin Oral Investig. 2024; 28(11):574.

PMID: 39373727 DOI: 10.1007/s00784-024-05979-7.

Supra-Alveolar Bone Regeneration: Progress, Challenges, and Future Perspectives.

Shakya A, Li Y, Chang N, Liu X Compos B Eng. 2024; 283.

PMID: 39071449 PMC: 11270636. DOI: 10.1016/j.compositesb.2024.111673.

Mussel-inspired electroactive, antibacterial and antioxidative composite membranes with incorporation of gold nanoparticles and antibacterial peptides for enhancing skin wound healing.

Dong Y, Wang Z, Wang J, Sun X, Yang X, Liu G J Biol Eng. 2024; 18(1):3.

PMID: 38212854 PMC: 10785445. DOI: 10.1186/s13036-023-00402-3.